Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26F4B7A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,674
Award facts
- Contract value 100% obligated
- $18,673.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,673.87 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 13, 2025, with a completion date of November 14, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic medication primarily indicated for rheumatoid arthritis and other inflammatory conditions, making this procurement consistent with the Defense Health Agency's pharmaceutical supply requirements for military beneficiaries.
This delivery order is issued under AmerisourceBergen's $999,999,999.00 IDC with the DLA Troop Support Medical through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, specialty pharmaceuticals, vaccines, and related medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through open competition, with its federal contract portfolio reflecting extensive deliveries of critical medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4B7A?
SPE2DR26F4B7A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F4B7A worth?
The government has obligated $18,674 on SPE2DR26F4B7A.
Is contract SPE2DR26F4B7A an order under another contract?
Yes. SPE2DR26F4B7A is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4B7A competed?
The extent of competition for SPE2DR26F4B7A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award